Efficacy and safety of Celsior preservation fluid in liver transplantation: One-year follow up of a prospective, multicenter, non-randomized study

Clinical Transplantation

Volumn 26, Issue 2, 2012, Pages 199-207

  Boudjema, Karim ^a   Grandadam, Stéphane ^a   Compagnon, Philippe ^a   Salamé, Ephrem ^b   Wolf, Philippe ^c   Ducerf, Christian ^d   Le Treut, Patrice ^e   Soubrane, Olivier ^f   Cherqui, Daniel ^g   Mouchel, Catherine ^a   Renault, Alain ^a   Bellissant, Eric ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b CHU CÔTE DE NACRE   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

^f Assistance Publique Hôpitaux de Paris Université Paris Descartes ^*  (France)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

Celsior; Graft survival; Liver transplantation; Preservation; University of Wisconsin solution

Indexed keywords

CELSIOR; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; COLD ISCHEMIA; COMPARATIVE STUDY; FATTY LIVER; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HEPATIC ARTERY; HUMAN; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PREDICTOR VARIABLE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOSINE; ADULT; ALLOPURINOL; DISACCHARIDES; ELECTROLYTES; FEMALE; GLUTAMATES; GLUTATHIONE; GRAFT SURVIVAL; HISTIDINE; HUMANS; INSULIN; LIVER TRANSPLANTATION; MALE; MANNITOL; MIDDLE AGED; ORGAN PRESERVATION SOLUTIONS; PRIMARY GRAFT DYSFUNCTION; RAFFINOSE;

EID: 84859843137     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01447.x     Document Type: Article

References (23)

1. Adam R, Cailliez V, Majno P et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry Study. Lancet 2000: 356: 621.
2. Kalayoglu M, Sollinger HW, Stratta RJ et al. Extended preservation of the liver for clinical transplantation. Lancet 1988: 1: 617.
3. Porte RJ, Ploeg RJ, McDonnell J, Cohen B. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transplant Int 1998: 11: 164.
4. Janssen H, Janssen PH, Broelsch CE. Celsior solution compared with University of Wisconsin solution (UW) and histidine-tryptophan-ketoglutarate solution (HTK) in the protection of human hepatocytes against ischemia-reperfusion injury. Transpl Int 2003: 16: 515.
5. Tolba RH, Akbar S, Müller A, Glatzel U, Minor T. Experimental liver preservation with Celsior: a novel alternative to University of Wisconsin and histidine-tryptophan-alpha-ketoglutarate solutions? Eur Surg Res 2000: 32: 142.
6. Mühlbacher F, Langer F, Mittermayer C. Preservation fluids for organ transplantation. Transplant Proc 1999: 31: 2069.
7. Pisarenko OI, Solomatina ES, Ivanov VE, Studneva IM, Kapelko VI, Smirnov VN. On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol 1985: 80: 126.
8. Menasché P, Termignon JL, Pradier F et al. Experimental evaluation of Celsior, a new heart preservation fluid. Eur J Cardiothorac Surg 1994: 8: 207.
9. Remadi JP, Baron O, Roussel JC et al. Myocardial preservation using Celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations. Ann Thorac Surg 2002: 73: 1495.
10. Vega JD, Ochsner JL, Jeevanandam V et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 2001: 71: 1442.
11. Baron O, Fabre S, Haloun A et al. Retrospective clinical comparison of Celsior solution to modified blood Wallwork solution in lung transplantation for cystic fibrosis. Prog Transplant 2002: 21: 176.
12. Nunes P, Mota A, Figueiredo A et al. Efficacy of renal preservation: comparative study of Celsior and University of Wisconsin solutions. Transplant Proc 2007: 39: 2478.
13. Boggi U, Vistoli F, Del Chiaro M et al. Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study. Transplantation 2004: 77: 1186.
14. Manrique A, Jiménez C, Herrero ML et al. Pancreas preservation with the University of Wisconsin versus Celsior solutions. Transplant Proc 2006: 38: 2582.
15. Audet M, Alexandre E, Mustun A et al. Comparative evaluation of Celsior solution versus Viaspan in a pig liver transplantation model. Transplantation 2001: 71: 1731.
16. Lechaux D, Dupont-Bierre E, Karam G et al. Technical aspects of combined heart, liver and kidney procurement. Ann Chir 2004: 129: 103.
17. Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS Liver Transplant Registry. Clin Transpl 2004: 148: 315.
18. Meneu Diaz JC, Vicente E, Nuño J et al. Prospective comparative study of the efficacy of Celsior solution for preservation in clinical liver transplant. Transplant Proc 2002: 34: 49.
19. Cavallari A, Cillo U, Nardo B et al. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003: 9: 814.
20. Pedotti P, Cardillo M, Rigotti P et al. A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 2004: 77: 1540.
21. Garcia-Gil FA, Arenas J, Güernes A et al. Preservation of the liver graft with Celsior solution. Transplant Proc 2006: 38: 2385.
22. Nardo B, Beltempo P, Bertelli R et al. Comparison of Celsior and University of Wisconsin solutions in cold preservation of liver from octogenarian donors. Transplant Proc 2004: 36: 523.
23. Karam G, Compagnon P, Hourmant M et al. A single solution for multiple organ procurement and preservation. Transplant Int 2005: 18: 657.